Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, today announced the presentation of initial data from its ongoing Phase 2 clinical trial of sitravatinib in...

Nektar Therapeutics (Nasdaq: NKTR) today announced the presentation of five clinical and preclinical data abstracts focused on its immuno-oncology portfolio at the 2019 Society for Immunotherapy...

Bolt Biotherapeutics, Inc., a private biotechnology company focused on using its Immune-Stimulating Antibody Conjugate (ISAC) platform technology to unleash the power of the immune system to treat...

Analysts and researchers who calculate and distribute some of the most coveted housing data in the nation took the stage Friday at the National Association of Realtors®' Residential Economic...

NexPoint Residential Trust, Inc. (NYSE: NXRT) ("NXRT") announced today that Brian Mitts, NXRT's Chief Financial Officer, Executive VP-Finance and Treasurer, Matt McGraner, NXRT's Executive VP and...